Calliditas Therapeutics — Major Shareholding Notification 2020

Nov 10, 2020

Issuer Calliditas Therapeutics AB

Holder

Investinor AS

Instrument

Instrument	Ordinary shares
Before the transaction
Shares	3,274,992
Voting rights	3,274,992
Transaction
Reason for major shareholding notification Sell
Date	09/11/2020
Limit for number of shares	5 %
Limit for number of votes	5 %
After the transaction
Quantity
Shares	166,803
Directly held voting rights	166,803
Indirectly held voting rights	0
Percentage
Directly held shares	0.334 %
Directly held voting rights	0.334 %
Indirectly held voting rights	0 %

Resulting distribution of total holdings

	Percentage of voting rights:	Number of underlying shares:
Shares	0.334 %	166,803
Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3
- Physically settled - Cash settled
Total	0.334 %	166,803
Group total holdings Voting rights 166,803 Percentage of voting rights 0.334
Published 10/11/2020 14:38

CLOSE PRINT

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25